文献速递肝胆胰外科

复发性肝细胞癌再次腹腔镜肝切除的可行性与疗效

Feasibility and efficacy of repeat laparoscopic liver resection for recurrent hepatocellular carcinoma.
PubMed 文献 · Surg Endosc · 2019-12-18

本研究回顾性比较42例再次开腹肝切除与30例再次腹腔镜肝切除治疗复发性肝细胞癌,发现再次腹腔镜组术中出血量更少(100 mL vs. 435 mL,P=0.001)、术后住院时间更短(10天 vs. 14.5天,P=0.002),并发症相当,结论为再次腹腔镜肝切除可行且短期疗效好。

要点

  • 再次腹腔镜肝切除治疗复发性肝细胞癌可行,短期疗效良好。
  • 与再次开腹肝切除相比,再次腹腔镜肝切除术中出血更少、住院时间更短。
  • 两组术后并发症相当,但需注意选择合适的患者。

核心结论

  • 再次腹腔镜肝切除治疗复发性肝细胞癌可行且有用,短期疗效良好,但需适当选择患者。

研究设计与样本

  • 回顾性比较研究,纳入2007年1月至2018年3月间42例再次开腹肝切除和30例再次腹腔镜肝切除的复发性肝细胞癌病例。

主要发现

  • 再次腹腔镜组中位术中出血量低于再次开腹组(100 mL vs. 435 mL,P=0.001)。
  • 再次腹腔镜组中位术后住院时间短于再次开腹组(10天 vs. 14.5天,P=0.002)。
  • 两组术后并发症等其他结果相当。
  • 再次腹腔镜组内按既往肝切除方式或肿瘤位置分层比较,术后临床特征无显著差异,但既往开腹肝切除者并发症率有升高趋势。

临床怎么用

  • 对于复发性肝细胞癌,再次腹腔镜肝切除可作为再次开腹肝切除的替代选择,但需注意患者选择。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Repeat hepatectomy is an acceptable treatment for recurrent hepatocellular carcinoma (HCC). However, repeat laparoscopic liver resection (LLR) has not been widely adopted due to its technical difficulty. This study aimed to assess the feasibility and efficacy of repeat LLR compared with repeat open liver resection (OLR) for recurrent HCC. METHODS: We performed 42 repeat OLR and 30 repeat LLR for cases of recurrent HCC between January 2007 and March 2018. This study retrospectively compared the patients' clinicopathological characteristics and operative and short-term outcomes including surgical time, intraoperative blood loss, duration of hospital stay, and postoperative complications between the two groups. RESULTS: There were no significant differences in patient characteristics between the two groups except in terms of Child-Pugh grade. The repeat LLR group had lower median intraoperative blood loss (100 mL vs. 435 mL; P = 0.001) and shorter median postoperative hospital stay (10 days vs. 14.5 days; P = 0.002). The other results including postoperative complications were comparable between the two groups. Further, comparison of two subpopulations of the repeat LLR group stratified by previous hepatectomy type (open or laparoscopic) or tumor location (segments 7 and 8 or other) revealed no significant differences in the postoperative clinical characteristics between them, although the morbidity rate tended to be higher in patients who underwent open hepatectomy for primary HCC than in patients who underwent laparoscopic hepatectomy. CONCLUSIONS: Repeat LLR for recurrent HCC is feasible and useful with good short-term outcomes although an appropriate patient selection seems to be necessary.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Onoe T, Yamaguchi M, Irei T, et al. Feasibility and efficacy of repeat laparoscopic liver resection for recurrent hepatocellular carcinoma. Surg Endosc. 2019. PMID: 31853630. doi:10.1007/s00464-019-07246-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。